References
Abe T, Tara LA, Lüdecke DK. Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. Neurosurgery 1999, 45: 1–10.
Bergamaschi S, Ronchi CL, Giavoli C, et al. Eight-yearfollow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy. Horm Res Paediatr 2010, 73: 74–9.
Schoof E, Dörr HG, Kiess W, et al. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism—effect of octreotide therapy. Horm Res 2004, 61: 184–9.
Goldenberg N, Racine MS, Thomas P, Degnan B, Chandler W, Barkan A. Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant. J Clin Endocrinol Metab 2008, 93: 2953–6.
Maheshwari HG, Prezant TR, Herman-Bonert V, Shahinian H, Kovacs K, Melmed S. Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma. J Clin Endocrinol Metab 2000, 85: 3409–16.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ciresi, A., Amato, M.C., Galluzzo, A. et al. Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: Efficacy of octreotide therapy. J Endocrinol Invest 34, 162–163 (2011). https://doi.org/10.1007/BF03347049
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347049